PROGNOSTIC STAGE IV BREAST CANCER AJCC V8
Clinical trials for PROGNOSTIC STAGE IV BREAST CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new PROGNOSTIC STAGE IV BREAST CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for PROGNOSTIC STAGE IV BREAST CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer brain metastasis drug combo trial halted early
Disease control TerminatedThis study tested two drugs, bintrafusp alfa and pimasertib, in people whose cancer had spread to the brain. The goal was to find the best dose and see if the combination could slow or stop tumor growth. The trial was stopped early after enrolling only 8 participants, so no clear…
Matched conditions: PROGNOSTIC STAGE IV BREAST CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Antifungal drug explored as brain tumor treatment – study halted early
Knowledge-focused TerminatedThis study looked at whether the antifungal drug ketoconazole could block a protein called tGLI1 in brain tumors. It included 15 adults with breast cancer that spread to the brain or with a type of brain tumor called glioma. The goal was to see if the drug could affect the tumor'…
Matched conditions: PROGNOSTIC STAGE IV BREAST CANCER AJCC V8
Phase: EARLY_PHASE1 • Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC